ResearcherFirst Affiliated Hospital of Dalian Medical UniversityActive in the last 2 years

Jifeng Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6829-7953; OpenAlex author ID A5100631834. Sources: OpenAlex.

Their work

Papers: 4 (first author 2, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2023: 2 papers · 2024: none · 2025: 2 papers

Papers 4

The Molecular Characteristics and Therapeutic Implications of O-glycan Synthesis in Pancreatic Cancer by Integrating Transcriptome and Single-cell Data. Co-author DOI 10.2174/0109298673293445240409060446 ↗
Multi-Omics Profiling Reveals Glycerolipid Metabolism-Associated Molecular Subtypes and Identifies ALDH2 as a Prognostic Biomarker in Pancreatic Cancer. Co-author DOI 10.3390/metabo15030207 ↗
Correlation between pancreatic cancer and metabolic syndrome: A systematic review and meta-analysis. First author DOI 10.3389/fendo.2023.1116582 ↗
Integrated multi-omics identified the novel intratumor microbiome-derived subtypes and signature to predict the outcome, tumor microenvironment heterogeneity, … First author DOI 10.3389/fphar.2023.1244752 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dong Shang · 2 shared papers, 2025 · strength 0.52
- Paper Multi-Omics Profiling Reveals Glycerolipid Metabolism-Associated Molecular Subtypes and Identifies ALDH2 as a Prognosti… DOI 10.3390/metabo15030207 ↗
- Paper The Molecular Characteristics and Therapeutic Implications of O-glycan Synthesis in Pancreatic Cancer by Integrating Tr… DOI 10.2174/0109298673293445240409060446 ↗
Biao Zhang · 2 shared papers, 2023–2025 · strength 0.44
- Paper The Molecular Characteristics and Therapeutic Implications of O-glycan Synthesis in Pancreatic Cancer by Integrating Tr… DOI 10.2174/0109298673293445240409060446 ↗
- Paper Integrated multi-omics identified the novel intratumor microbiome-derived subtypes and signature to predict the outcome… DOI 10.3389/fphar.2023.1244752 ↗
Dawei Deng · 1 shared paper, 2025 · strength 0.27
- Paper Multi-Omics Profiling Reveals Glycerolipid Metabolism-Associated Molecular Subtypes and Identifies ALDH2 as a Prognosti… DOI 10.3390/metabo15030207 ↗
Peiyuan Yin · 1 shared paper, 2025 · strength 0.27
- Paper Multi-Omics Profiling Reveals Glycerolipid Metabolism-Associated Molecular Subtypes and Identifies ALDH2 as a Prognosti… DOI 10.3390/metabo15030207 ↗
Lei Zhong · 1 shared paper, 2023 · strength 0.26
- Paper Correlation between pancreatic cancer and metabolic syndrome: A systematic review and meta-analysis. DOI 10.3389/fendo.2023.1116582 ↗
Guang Tan · 1 shared paper, 2023 · strength 0.26
- Paper Correlation between pancreatic cancer and metabolic syndrome: A systematic review and meta-analysis. DOI 10.3389/fendo.2023.1116582 ↗
Binqian Huang · 1 shared paper, 2025 · strength 0.26
- Paper The Molecular Characteristics and Therapeutic Implications of O-glycan Synthesis in Pancreatic Cancer by Integrating Tr… DOI 10.2174/0109298673293445240409060446 ↗
Qihang Yuan · 1 shared paper, 2025 · strength 0.26
- Paper The Molecular Characteristics and Therapeutic Implications of O-glycan Synthesis in Pancreatic Cancer by Integrating Tr… DOI 10.2174/0109298673293445240409060446 ↗
Shilin Xia · 1 shared paper, 2025 · strength 0.26
- Paper The Molecular Characteristics and Therapeutic Implications of O-glycan Synthesis in Pancreatic Cancer by Integrating Tr… DOI 10.2174/0109298673293445240409060446 ↗
Zhizhou Wang · 1 shared paper, 2023 · strength 0.18
- Paper Integrated multi-omics identified the novel intratumor microbiome-derived subtypes and signature to predict the outcome… DOI 10.3389/fphar.2023.1244752 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.